Sage Journals: Discover world-class research

Retricted access

Research article

First published 2020-6

Tolerance of Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) Inhibitors in Patients With Self-Reported Statin Intolerance

Erica R. Davidson, Melissa J. Snider, Kelly Bartsch [...]

Journal of Pharmacy Practice

Free access

Review article

First published 2018-1

Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables

Theodosios D. Filippatos, Anastazia Kei, Christos V. Rizos [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Open access

Research article

First published 2019

Management of patients eligible for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: economic impact and reform proposals

Claudio Jommi, Marianna Cavazza

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Open access

Research article

First published 2026-1

Causal effects of lipid-lowering drug targets on psychiatric disorders: A drug–target Mendelian randomization study

Yan Wang, Xin Liu, Shuo Huang

Journal of International Medical Research

Free access

Research article

First published 2021-1

Lipoprotein Apheresis and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia: A One Center Study

Vana Kolovou, Niki Katsiki, Stamatis Makrygiannis [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Free access

Editorial

First published 2017-1

Hypothesis

Wenguang Wang, Chao Liu, Hongliang Cong

Journal of Cardiovascular Pharmacology and Therapeutics

Free access

Research article

First published 2019-1

The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients

Eric J. Brandt, Lane B. Benes, Linda Lee [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Open access

Case report

First published 2019

Fatal Recurrent Staphylococcus aureus Infection in a Patient With an Aortic Endostent Under Alirocumab

Claudia Stöllberger, Gerard Mertikian, Dorit Stahl [...]

Infectious Diseases: Research and Treatment

Free access

Research article

First published 2018-7

The Pharmacologic Role and Clinical Utility of PCSK9 Inhibitors for the Treatment of Hypercholesterolemia

C. Michael White

Journal of Cardiovascular Pharmacology and Therapeutics

Free access

Case report

First published 2025-1

A case of autoimmune hepatitis associated with the PCSK9 inhibitor alirocumab

Amira Ibrahim, Geeta Prasad, Eric S Kilpatrick [...]

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Search results